SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celgene-CELG
CELG 108.240.0%Nov 22 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote ()4/8/1999 12:39:00 AM
From: scaram(o)uche  Read Replies (2) of 804
 
Bone Marrow Angiogenesis Has Prognostic Value in
Multiple Myeloma: An Eastern Cooperative Oncology
Group Study

General Poster
Session:
Lymphomas and Myelomas
Date:
"May 17, 1999"
Time:
1:00 PM - 5:00 PM
Location:
Hall C (East Wing)

Bone Marrow Neo-Angiogenesis in Multiple Myeloma
Predicts Poor Prognosis

General Poster
Session:
Lymphomas and Myelomas
Date:
"May 17, 1999"
Time:
1:00 PM - 5:00 PM
Location:
Hall C (East Wing)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News